Skip to main content
Year archive

Bavarian Nordic — 2019 filings

All 113 regulatory filings released by Bavarian Nordic (BAVA) in 2019, sourced directly from the official regulator.

113 Filings
2019 Period
2019 filings (113)
Filing Released Lang
Bavarian Nordic Announces Closing of Acquisition of Rabipur/RabAvert and Encepur from GlaxoSmithKline and Updates Year-end Cash Preparedness
Capital/Financing Update
2019-12-31 English
Bavarian Nordic Announces Closing of Acquisition of Rabipur/RabAvert and Encepur from GlaxoSmithKline and Updates Year-end Cash Preparedness
M&A Activity
2019-12-31 English
M&A Activity 2019
M&A Activity
2019-12-31 Danish
M&A Activity 2019
M&A Activity
2019-12-31 English
Bavarian Nordic Announces the Sale of Priority Review Voucher
Capital/Financing Update
2019-12-17 Danish
Bavarian Nordic Announces the Sale of Priority Review Voucher
Capital/Financing Update
2019-12-17 Danish
Regulatory Filings 2019
Regulatory Filings
2019-12-17 English
Share Issue/Capital Change 2019
Share Issue/Capital Change
2019-12-17 English
Bavarian Nordic Receives Antitrust Clearance for Acquisition of Rabipur/RabAvert and Encepur from GlaxoSmithKline
M&A Activity
2019-12-13 Danish
Bavarian Nordic Receives Antitrust Clearance for Acquisition of Rabipur/RabAvert and Encepur from GlaxoSmithKline
M&A Activity
2019-12-13 English
Regulatory Filings 2019
Regulatory Filings
2019-12-13 Danish
M&A Activity 2019
M&A Activity
2019-12-13 English
Bavarian Nordic Announces Submission of European Marketing Authorisation Applications for Investigational Ebola Vaccine Regimen
Regulatory Filings
2019-11-07 Danish
Bavarian Nordic Announces Submission of European Marketing Authorisation Applications for Investigational Ebola Vaccine Regimen
Regulatory Filings
2019-11-07 English
Regulatory Filings 2019
Regulatory Filings
2019-11-07 English
Regulatory Filings 2019
Regulatory Filings
2019-11-07 Danish
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
Director's Dealing
2019-11-07 Danish
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
Director's Dealing
2019-11-07 Danish
Director's Dealing 2019
Director's Dealing
2019-11-07 English
Director's Dealing 2019
Director's Dealing
2019-11-07 English
Bavarian Nordic Announces Interim Results for the First Nine Months of 2019
Interim / Quarterly Report 9M 2019
2019-11-07 English
Bavarian Nordic Announces Interim Results for the First Nine Months of 2019
Interim / Quarterly Report 9M 2019
2019-11-07 English
Earnings Release 2019
Earnings Release 9M 2019
2019-11-07 English
Earnings Release 2019
Earnings Release 9M 2019
2019-11-07 Danish
Bavarian Nordic A/S – Notice Convening Extraordinary General Meeting
Proxy Solicitation & Information Statement
2019-10-25 English
Bavarian Nordic A/S - Indkaldelse til ekstraordinær generalforsamling
AGM Information
2019-10-25 Danish
Bavarian Nordic offentliggør transformerende køb af to markedsførte vacciner fra GlaxoSmithKline
M&A Activity
2019-10-21 Danish
Bavarian Nordic Announces a Transformative Acquisition of Two Established Commercial Vaccines from GlaxoSmithKline
Capital/Financing Update
2019-10-21 English
Bavarian Nordic Announces a Transformative Acquisition of Two Established Commercial Vaccines from GlaxoSmithKline
Regulatory Filings
2019-10-21 Danish
Bavarian Nordic Announces a Transformative Acquisition of Two Established Commercial Vaccines from GlaxoSmithKline
M&A Activity
2019-10-21 English
M&A Activity 2019
M&A Activity
2019-10-21 English
M&A Activity 2019
M&A Activity
2019-10-21 Danish
Bavarian Nordic opdaterer omkring fase 2-forsøget med CV301 i blærekræft
Regulatory Filings
2019-10-18 Danish
Bavarian Nordic Updates on Phase 2 Study of CV301 in Bladder Cancer
Earnings Release FY 2019
2019-10-18 English
Bavarian Nordic Updates on Phase 2 Study of CV301 in Bladder Cancer
Regulatory Filings
2019-10-18 Danish
Bavarian Nordic Updates on Phase 2 Study of CV301 in Bladder Cancer
Regulatory Filings
2019-10-18 Danish
Regulatory Filings 2019
Regulatory Filings
2019-10-18 English
Regulatory Filings 2019
Regulatory Filings
2019-10-18 English
Bavarian Nordic indleder fase 1 forsøg med vaccine mod hesteencephalit virus
Report Publication Announcement
2019-10-08 Danish
Bavarian Nordic Announces Initiation of Phase 1 Clinical Trial of Equine Encephalitis Virus Vaccine
Regulatory Filings
2019-10-08 English
Bavarian Nordic Announces Initiation of Phase 1 Clinical Trial of Equine Encephalitis Virus Vaccine
Regulatory Filings
2019-10-08 Danish
Bavarian Nordic Announces Initiation of Phase 1 Clinical Trial of Equine Encephalitis Virus Vaccine
Regulatory Filings
2019-10-08 English
Legal Proceedings Report 2019
Legal Proceedings Report
2019-10-08 English
Regulatory Filings 2019
Regulatory Filings
2019-10-08 English
Bavarian Nordic Announces U.S. FDA Approval of JYNNEOS™ (Smallpox and Monkeypox Vaccine, Live, Non-replicating) for Prevention of Smallpox and Monkeypox Disease in Adults
Regulatory Filings
2019-09-24 English
Bavarian Nordic Announces U.S. FDA Approval of JYNNEOS™ (Smallpox and Monkeypox Vaccine, Live, Non-replicating) for Prevention of Smallpox and Monkeypox Disease in Adults
Regulatory Filings
2019-09-24 English
Bavarian Nordic Announces U.S. FDA Approval of JYNNEOS™ (Smallpox and Monkeypox Vaccine, Live, Non-replicating) for Prevention of Smallpox and Monkeypox Disease in Adults
Regulatory Filings
2019-09-24 English
Bavarian Nordic Announces U.S. FDA Approval of JYNNEOS™ (Smallpox and Monkeypox Vaccine, Live, Non-replicating) for Prevention of Smallpox and Monkeypox Disease in Adults
Regulatory Filings
2019-09-24 English
Bavarian Nordic Announces U.S. FDA Approval of JYNNEOS™ (Smallpox and Monkeypox Vaccine, Live, Non-replicating) for Prevention of Smallpox and Monkeypox Disease in Adults
Regulatory Filings
2019-09-24 English
Bavarian Nordic Announces U.S. FDA Approval of JYNNEOS™ (Smallpox and Monkeypox Vaccine, Live, Non-replicating) for Prevention of Smallpox and Monkeypox Disease in Adults
Regulatory Filings
2019-09-24 English
Bavarian Nordic Announces U.S. FDA Approval of JYNNEOS™ (Smallpox and Monkeypox Vaccine, Live, Non-replicating) for Prevention of Smallpox and Monkeypox Disease in Adults
Regulatory Filings
2019-09-24 English
Earnings Release 2019
Earnings Release Q3 2019
2019-09-24 English
Regulatory Filings 2019
Regulatory Filings
2019-09-24 English
Bavarian Nordic A/S - Vedtægter
Regulatory Filings
2019-08-29 English
Bavarian Nordic A/S - Articles of Association
Report Publication Announcement
2019-08-29 English
Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise
Share Issue/Capital Change
2019-08-29 English
Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise
Share Issue/Capital Change
2019-08-29 English
Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise
Share Issue/Capital Change
2019-08-29 English
Kapitalforhøjelse i Bavarian Nordic A/S som følge af medarbejderes udnyttelse af tegningsoptioner
Share Issue/Capital Change
2019-08-29 Danish
Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise
Share Issue/Capital Change
2019-08-29 Danish
Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise
Share Issue/Capital Change
2019-08-29 English
Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise
Share Issue/Capital Change
2019-08-29 English
Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise
Share Issue/Capital Change
2019-08-29 Danish
Bavarian Nordic Announces First Half 2019 Results
Report Publication Announcement
2019-08-15 English
Bavarian Nordic Announces First Half 2019 Results
Report Publication Announcement
2019-08-15 English
Bavarian Nordic Announces First Half 2019 Results
Report Publication Announcement
2019-08-15 English
Bavarian Nordic offentliggør regnskab for første halvår 2019
Report Publication Announcement H2 2019
2019-08-15 English
Bavarian Nordic Announces First Half 2019 Results
Report Publication Announcement H1 2019
2019-08-15 English
Bavarian Nordic Announces First Half 2019 Results
Interim / Quarterly Report H1 2019
2019-08-15 English
Earnings Release 2019
Earnings Release H1 2019
2019-08-15 English
Interim / Quarterly Report 2019
Interim / Quarterly Report H1 2019
2019-08-15 English
Bavarian Nordic Initiates Phase 3 Trial of Freeze-dried MVA-BN® Smallpox Vaccine
Regulatory Filings
2019-06-19 Danish
Bavarian Nordic Initiates Phase 3 Trial of Freeze-dried MVA-BN® Smallpox Vaccine
Regulatory Filings
2019-06-19 English
Regulatory Filings 2019
Regulatory Filings
2019-06-19 English
Regulatory Filings 2019
Regulatory Filings
2019-06-19 English
Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise
Share Issue/Capital Change
2019-06-06 Danish
Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise
Share Issue/Capital Change
2019-06-06 Danish
Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise
Share Issue/Capital Change
2019-06-06 English
Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise
Share Issue/Capital Change
2019-06-06 English
Bavarian Nordic Reports Positive Result from ongoing Phase 2 Trial Evaluating BN-Brachyury in Chordoma
Regulatory Filings
2019-06-05 Danish
Bavarian Nordic Reports Positive Result from ongoing Phase 2 Trial Evaluating BN-Brachyury in Chordoma
Regulatory Filings
2019-06-05 English
Regulatory Filings 2019
Regulatory Filings
2019-06-05 English
Legal Proceedings Report 2019
Legal Proceedings Report
2019-06-05 Danish
Bavarian Nordic – Transactions in Connection with Share Buy-Back Program and Termination of Share Buy-Back Program
Transaction in Own Shares
2019-06-03 Danish
Bavarian Nordic – Transactions in Connection with Share Buy-Back Program and Termination of Share Buy-Back Program
Transaction in Own Shares
2019-06-03 English
Transaction in Own Shares 2019
Transaction in Own Shares
2019-06-03 English
Transaction in Own Shares 2019
Transaction in Own Shares
2019-06-03 English
Bavarian Nordic Launches Share Buy-Back Program to Hedge Incentive Scheme Obligations
Transaction in Own Shares
2019-05-22 Danish
Bavarian Nordic Launches Share Buy-Back Program to Hedge Incentive Scheme Obligations
Transaction in Own Shares
2019-05-22 Danish
Transaction in Own Shares 2019
Transaction in Own Shares
2019-05-22 English
Transaction in Own Shares 2019
Transaction in Own Shares
2019-05-22 English
Report Publication Announcement 2018
Report Publication Announcement FY 2018
2019-03-21 Danish
Audit Report / Information 2018
Audit Report / Information FY 2018
2019-03-21 English
Report Publication Announcement 2018
Report Publication Announcement FY 2018
2019-03-21 English
Bavarian Nordic Announces Annual Report 2018
Report Publication Announcement
2019-03-21 English
Bavarian Nordic Announces Annual Report 2018
Annual Report FY 2018
2019-03-21 English
Regulatory Filings 2019
Regulatory Filings
2019-03-11 Danish
Legal Proceedings Report 2019
Legal Proceedings Report
2019-03-11 English
Regulatory Filings 2019
Regulatory Filings
2019-03-11 English
Bavarian Nordic meddeler en forsinkelse af de amerikanske sundhedsmyndigheders behandling af registreringsansøgningen for MVA-BN® koppevaccine
Regulatory Filings
2019-03-11 Danish
Bavarian Nordic meddeler en forsinkelse af de amerikanske sundhedsmyndigheders behandling af registreringsansøgningen for MVA-BN® koppevaccine
Regulatory Filings
2019-03-11 Danish
Bavarian Nordic Announces FDA Delay in the Review of the Biologics License Application for MVA-BN Smallpox Vaccine
Regulatory Filings
2019-03-11 English
Regulatory Filings 2019
Regulatory Filings
2019-02-21 English
Regulatory Filings 2019
Regulatory Filings
2019-02-21 English
Regulatory Filings 2019
Regulatory Filings
2019-02-21 Danish
Bavarian Nordic Announces Initiation of Phase 1/2a Clinical Trial of Therapeutic HPV Vaccine Regimen in Collaboration with Janssen
Regulatory Filings
2019-02-21 English
Bavarian Nordic Announces Initiation of Phase 1/2a Clinical Trial of Therapeutic HPV Vaccine Regimen in Collaboration with Janssen
Regulatory Filings
2019-02-21 English
Regulatory Filings 2019
Regulatory Filings
2019-01-18 English
Regulatory Filings 2019
Regulatory Filings
2019-01-18 Danish
Regulatory Filings 2019
Regulatory Filings
2019-01-18 English
Den amerikanske regering udnytter option på USD 44 mio. under kontrakt på frysetørret MVA-BN® koppevaccine
Regulatory Filings
2019-01-18 Danish
Den amerikanske regering udnytter option på USD 44 mio. under kontrakt på frysetørret MVA-BN® koppevaccine
Capital/Financing Update
2019-01-18 Danish
Bavarian Nordic Announces Exercise of USD 44 Million Option by the U.S. Government under Contract for Freeze-dried MVA-BN® Smallpox Vaccine
Regulatory Filings
2019-01-18 English